Cianna Medical welcomes Tom Umbel to its Board of Directors

– USA, CA – Cianna Medical, Inc., a women’s health company dedicated to developing innovative technologies for the treatment of early-stage breast cancer, announced that Tom Umbel has been elected to its Board of Directors. Mr. Umbel brings over 30 years of experience to the Director role, most recently as Group Senior Vice President, Corporate Development and Marketing for Hologic, Inc. a developer, manufacturer and supplier of diagnostic and medical imaging systems related to women’s health.

“We are delighted to welcome Mr. Umbel as a member of our Board,” said Jill Anderson, President and Chief Executive Officer of Cianna Medical. “Mr. Umbel was instrumental in the acquisition of over 20 companies, many technology acquisitions and several marketing alliances during his tenure at Hologic, Inc. We are confident that Mr. Umbel will make a significant contribution to Cianna Medical’s growth in women’s health.”

Mr. Umbel currently serves as Vice President of Business Development for Bioventus, a privately owned ortho-biologics company spun out from Smith & Nephew.

About Cianna Medical, Inc.

Cianna Medical develops, manufactures and markets innovative medical technologies that reduce costs, improve quality, and reduce the burden breast cancer treatment places on women and their families. Its SAVI® technologies are FDA-cleared and address unmet needs in the delivery of radiation therapy, tumor localization and surgical guidance.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team

here the original post =>